Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06326983 · ClinicalTrials.gov registry record · NA
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
A NA study of Pain and Anesthesia, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT06326983: Recruiting NA study of Pain and Anesthesia, sponsored by Boston Children's Hospital.
NCT06326983 is a NA study of Pain and Anesthesia that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 58 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06326983, a NA study of Pain and Anesthesia, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, randomized, controlled, non-inferiority study of patients undergoing tonsil surgeries at Boston Children's Hospital Waltham. The overall aim is to evaluate the efficacy of an opioid anesthetic plan (morphine, ketorolac, and acetaminophen versus an opioid sparing anesthetic plan (dexmedetomidine, ketorolac and acetaminophen) for perioperative analgesia and recovery time in patients undergoing tonsillectomies and tonsillotomies at Boston Children's Hospital Waltham. Secondary measures include rescue opioids administered in post-anesthesia care unit (PACU), re-operation secondary to bleeding, emergence delirium, post-operative nausea and vomiting, intraoperative hemodynamics, intraoperative vasopressor administration, and length of procedure.
Primary Outcome
Median Pain Scores in the Post-Anesthesia Care Unit measured by the numeric rating scale (NRS), Wong-Baker Faces scale or FLACC (Face, Legs, Activity, Cry, Consolability) scale as indicated based on patient age and development. All scales are done on a 0-10 point scale with 0 being no pain and 10 being the highest pain.
Conditions Studied
Interventions
- DRUG Acetaminophen
- DRUG Ketorolac
- DRUG Dexmedetomidine
- DRUG Morphine
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Waltham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2024-05-09 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What NCT06326983 shows while recruiting
NCT06326983 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (81% lower).
The record links to 6 conditions, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Acetaminophen is the first listed.
NCT06326983 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06326983 about?
NCT06326983 is a clinical study titled "Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery". This is a prospective, randomized, controlled, non-inferiority study of patients undergoing tonsil surgeries at Boston Children's Hospital Waltham. The overall aim is to evaluate the efficacy of an opioid anesthetic plan (morphine, ketorolac, and acetaminophen versus an opioid sparing anesthetic pla...
What is the current status of trial NCT06326983?
This trial is currently recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2024-05-09. Estimated completion is 2026-04-01.
What conditions does trial NCT06326983 study?
This clinical trial studies the following conditions: Pain, Anesthesia, Tonsillitis, Emergence Delirium, Post-operative Nausea and Vomiting (PONV).
What interventions are being tested in trial NCT06326983?
The interventions under investigation include: Acetaminophen (DRUG), Ketorolac (DRUG), Dexmedetomidine (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT06326983?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06326983 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06326983's enrollment target sits among peer trials
58 242nd of 374 higher than 132 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI